Search - tctmd.com

Displaying 381 - 400 of 565

Sort: Relevancy | Date

News Conference News TCT 2015

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

October 11, 2015

News Conference News TCT 2015

Cath Lab Economics: Pursuit of a Light at the End of the Tunnel

Nicole Lou

October 11, 2015

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

News Conference News TCT 2014

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Yael L. Maxwell

September 19, 2014

News Conference News TCT 2014

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

September 19, 2014

News Conference News TCT 2014

I-LOVE-IT 2: Biodegradable Polymer SES as Effective as Durable Polymer SES in All-Comers

September 17, 2014

News Conference News TCT 2014

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

September 17, 2014

Presentation TCT 2014

Left Main Stent Thrombosis: New Insights Into the Scope of the Problem

Presenter: Davide Capodanno, Evald H. Christiansen, R. Stefan Kiesz, Patrick W. Serruys

September 16, 2014

News Conference News TCT 2014

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

September 16, 2014

Presentation TCT 2014

Practical Integration: A Modern Cath Lab-Based Imaging Service (and Lessons Learned)

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Ning Guo

September 15, 2014

Presentation TCT 2014

Case #8: Early Stent Thrombosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Neal Uren

September 15, 2014

Presentation TCT 2014

Case #7: In-Stent Restenosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Bernhard Witzenbichler

September 15, 2014

Presentation TCT 2014

Mechanisms, Predictors, and Unusual Causes of Early, Late, and Very Late Stent Thrombosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Fernando Alfonso

September 15, 2014

Presentation TCT 2014

Mechanisms, Predictors, and Unusual Causes of In-Stent Restenosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Lisette Okkels Jensen

September 15, 2014

Presentation TCT 2014

Definitely To Prevent Stent Thrombosis and MI!

Presenter: Gregg W. Stone

September 15, 2014

Presentation TCT 2014

Cangrelor III: Detailed Effects on Intraprocedural and Postprocedural Stent Thrombosis

Presenter: Christian W. Hamm, Franz-Josef Neumann, Philippe Généreux

September 15, 2014

News Conference News TCT 2014

VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size

September 15, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

News Conference News TCT 2014

PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI

September 15, 2014

News Conference News TCT 2014

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

September 15, 2014

Advertisement

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

Cath Lab Economics: Pursuit of a Light at the End of the Tunnel

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

I-LOVE-IT 2: Biodegradable Polymer SES as Effective as Durable Polymer SES in All-Comers

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

Left Main Stent Thrombosis: New Insights Into the Scope of the Problem

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

Practical Integration: A Modern Cath Lab-Based Imaging Service (and Lessons Learned)

Case #8: Early Stent Thrombosis

Case #7: In-Stent Restenosis

Mechanisms, Predictors, and Unusual Causes of Early, Late, and Very Late Stent Thrombosis

Mechanisms, Predictors, and Unusual Causes of In-Stent Restenosis

Definitely To Prevent Stent Thrombosis and MI!

Cangrelor III: Detailed Effects on Intraprocedural and Postprocedural Stent Thrombosis

VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content